PMID- 37809324
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231030
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 10
DP  - 2023
TI  - Fatty infiltration of the pancreas: a systematic concept analysis.
PG  - 1227188
LID - 10.3389/fmed.2023.1227188 [doi]
LID - 1227188
AB  - Fatty infiltration of the pancreas (FIP) has been recognized for nearly a 
      century, yet many aspects of this condition remain unclear. Regular literature 
      reviews on the diagnosis, consequences, and management of FIP are crucial. This 
      review article highlights the various disorders for which FIP has been 
      established as a risk factor, including type 2 diabetes mellitus (T2DM), 
      pancreatitis, pancreatic fistula (PF), metabolic syndrome (MS), polycystic ovary 
      syndrome (PCOS), and pancreatic duct adenocarcinoma (PDAC), as well as the new 
      investigation tools. Given the interdisciplinary nature of FIP research, a broad 
      range of healthcare specialists are involved. This review article covers key 
      aspects of FIP, including nomenclature and definition of pancreatic fat 
      infiltration, history and epidemiology, etiology and pathophysiology, clinical 
      presentation and diagnosis, clinical consequences, and treatment. This review is 
      presented in a detailed narrative format for accessibility to clinicians and 
      medical students.
CI  - Copyright (c) 2023 Mahyoub, Elhoumed, Maqul, Almezgagi, Abbas, Jiao, Wang, 
      Alnaggar, Zhao and He.
FAU - Mahyoub, Mueataz A
AU  - Mahyoub MA
AD  - Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Clinical Medical Research Center for Digestive Diseases (Oncology) of Shaanxi 
      Province, Xi'an, China.
AD  - Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Department of Gastroenterology, Faculty of Medicine, Thamar University, Dhamar, 
      Yemen.
FAU - Elhoumed, Mohamed
AU  - Elhoumed M
AD  - Department of Epidemiology and Biostatistics, School of Public Health, Xi'an 
      Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
AD  - National Institute of Public Health Research (INRSP), Nouakchott, Mauritania.
FAU - Maqul, Abdulfatah Hassan
AU  - Maqul AH
AD  - Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Department of Medical Imaging, Sahan Diagnostic Center, Mogadishu, Somalia.
FAU - Almezgagi, Maged
AU  - Almezgagi M
AD  - The Key Laboratory of High-altitude Medical Application of Qinghai Province, 
      Xining, Qinghai, China.
AD  - Department of Immunology, Qinghai University, Xining, Qinghai, China.
AD  - Department of Medical Microbiology, Faculty of Sciences, Ibb University, Ibb, 
      Yemen.
FAU - Abbas, Mustafa
AU  - Abbas M
AD  - Department of Internal Medicine, Faculty of Medicine, Thamar University, Dhamar, 
      Yemen.
FAU - Jiao, Yang
AU  - Jiao Y
AD  - Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
FAU - Wang, Jinhai
AU  - Wang J
AD  - Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
FAU - Alnaggar, Mohammed
AU  - Alnaggar M
AD  - Department of Oncology, South Hubei Cancer Hospital, Xianning, Hubei, China.
AD  - Department of Internal Medicine, Clinic Medical College, Hubei University of 
      Science and Technology, Xianning, Hubei, China.
FAU - Zhao, Ping
AU  - Zhao P
AD  - Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
FAU - He, Shuixiang
AU  - He S
AD  - Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong 
      University, Xi'an, China.
AD  - Clinical Medical Research Center for Digestive Diseases (Oncology) of Shaanxi 
      Province, Xi'an, China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230922
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC10556874
OTO - NOTNLM
OT  - fatty infiltration of the pancreas
OT  - metabolic syndrome
OT  - obesity
OT  - pancreatic duct adenocarcinoma
OT  - type 2 diabetes mellitus
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/10/09 06:41
MHDA- 2023/10/09 06:42
PMCR- 2023/09/22
CRDT- 2023/10/09 05:53
PHST- 2023/05/22 00:00 [received]
PHST- 2023/08/30 00:00 [accepted]
PHST- 2023/10/09 06:42 [medline]
PHST- 2023/10/09 06:41 [pubmed]
PHST- 2023/10/09 05:53 [entrez]
PHST- 2023/09/22 00:00 [pmc-release]
AID - 10.3389/fmed.2023.1227188 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2023 Sep 22;10:1227188. doi: 10.3389/fmed.2023.1227188. 
      eCollection 2023.